US FDA requires major changes to opioid pain medication labelling to emphasize risks

The US Food and Drug Administration (FDA) is requiring safety labelling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use. These changes follow a public

To access the full article, please log in or subscribe.